Clinical Trials Directory

Trials / Unknown

UnknownNCT02940054

RED-FLAGS Index Validation in Crohn's Disease Patients

Validation of the RED-FLAGS Index for Early Diagnosis of Crohn's Disease: Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Observational prospective study to validate a new index for early diagnosis of Crohn's disease (CD)

Detailed description

The study will be conducted in Italian referral centers for Crohn's disease and will involve general practitioners (GPs) for RED-Flags Index validation. The project is divided into two phases. 1. retrospective phase (4 weeks). All the general practitioners participating to the study will extrapolate from their patient's database, the total number of patients with a Crohn's disease diagnosis performed in the past. The date of diagnosis will be indicated. No other information will be provided. These data will be then analyzed to obtain, for each GP, the total number of CD diagnosed in each semester. 2. retrospective phase (6 months). GPs will administer the RED-Flags questionnaire to all patients that meet inclusion and exclusion criteria, after informed consent signature. All these patients will be then referred to the nearest referral center, to be evaluated by a gastroenterologist specialized in CD, to confirm or exclude a CD.

Conditions

Interventions

TypeNameDescription
OTHERRed-flags questionnaireA questionnaire composed by 8 items will be administered by GPs to those patients and they will be referred to a gastroenterologist with expertise in CD. All those patients will be evaluated, as per usual practice, to confirm or exclude Crohn's disease.

Timeline

Start date
2015-02-01
Primary completion
2017-12-01
Completion
2018-03-01
First posted
2016-10-20
Last updated
2016-10-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02940054. Inclusion in this directory is not an endorsement.